• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。

From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.

机构信息

Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital of Fujian Medical University, Respirology Medicine Centre of Fujian Province, 34 Zhongshanbei Road, Licheng District, Quanzhou, China.

Department of Ultrasound Medicine, the Second Affiliated Hospital of Fujian Medical University, 34 Zhongshanbei Road, Licheng District, Quanzhou, China.

出版信息

Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.

DOI:10.1186/s12931-020-01479-w
PMID:32854739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7450684/
Abstract

Within two decades, there have emerged three highly pathogenic and deadly human coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden and health threats caused by these coronaviruses are extremely dreadful and getting more serious as the increasing number of global infections and attributed deaths of SARS-CoV-2 and MERS-CoV. Unfortunately, specific medical countermeasures for these hCoVs remain absent. Moreover, the fast spread of misinformation about the ongoing SARS-CoV-2 pandemic uniquely places the virus alongside an annoying infodemic and causes unnecessary worldwide panic. SARS-CoV-2 shares many similarities with SARS-CoV and MERS-CoV, certainly, obvious differences exist as well. Lessons learnt from SARS-CoV and MERS-CoV, timely updated information of SARS-CoV-2 and MERS-CoV, and summarized specific knowledge of these hCoVs are extremely invaluable for effectively and efficiently contain the outbreak of SARS-CoV-2 and MERS-CoV. By gaining a deeper understanding of hCoVs and the illnesses caused by them, we can bridge knowledge gaps, provide cultural weapons for fighting and controling the spread of MERS-CoV and SARS-CoV-2, and prepare effective and robust defense lines against hCoVs that may emerge or reemerge in the future. To this end, the state-of-the-art knowledge and comparing the biological features of these lethal hCoVs and the clinical characteristics of illnesses caused by them are systematically summarized in the review.

摘要

在短短二十年内,出现了三种高致病性和致命性的人类冠状病毒,即 SARS-CoV、MERS-CoV 和 SARS-CoV-2。这些冠状病毒造成的经济负担和健康威胁极其可怕,而且随着 SARS-CoV-2 和 MERS-CoV 感染人数的不断增加和归因死亡人数的增加,情况变得更加严重。不幸的是,目前仍然缺乏针对这些 hCoV 的特定医疗对策。此外,关于正在发生的 SARS-CoV-2 大流行的错误信息迅速传播,这使得该病毒与令人讨厌的信息泛滥一起,引起了不必要的全球恐慌。SARS-CoV-2 与 SARS-CoV 和 MERS-CoV 有许多相似之处,但肯定也存在明显的差异。从 SARS-CoV 和 MERS-CoV 中吸取的教训、及时更新的 SARS-CoV-2 和 MERS-CoV 信息,以及总结的这些 hCoV 的特定知识,对于有效和高效地控制 SARS-CoV-2 和 MERS-CoV 的爆发极为宝贵。通过更深入地了解 hCoV 及其引起的疾病,我们可以弥合知识差距,为抗击和控制 MERS-CoV 和 SARS-CoV-2 的传播提供文化武器,并为未来可能出现或再次出现的 hCoV 做好有效的、强大的防御准备。为此,本文在综述中系统地总结了这些致命 hCoV 的最新知识和比较它们的生物学特征以及它们引起的疾病的临床特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd27/7450791/bf9c62c5878e/12931_2020_1479_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd27/7450791/06f298499245/12931_2020_1479_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd27/7450791/bf9c62c5878e/12931_2020_1479_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd27/7450791/06f298499245/12931_2020_1479_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd27/7450791/bf9c62c5878e/12931_2020_1479_Fig2_HTML.jpg

相似文献

1
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.
2
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.新出现的冠状病毒:首例SARS、第二例MERS和第三例SARS-CoV-2:新型冠状病毒肺炎的流行病学新进展
Infez Med. 2020 Jun 1;28(suppl 1):6-17.
3
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.新型冠状病毒 SARS-CoV-2、SARS-CoV 和中东呼吸综合征冠状病毒(MERS-CoV)相关病毒性肺炎的研究:文献综述。
APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047.
4
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.冠状病毒发病机制的分子基础:以比较基因组学方法研究行星健康,以预防 21 世纪的人畜共患病爆发。
OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16.
5
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?为何 COVID-19 的传播效率和攻击性比以往冠状病毒疫情中的病毒传播更高?
Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312.
6
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.新型冠状病毒表现的全面综述——在致命的 COVID-19 全球大流行背景下。
Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11.
7
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.SARS-CoV-2、SARS-CoV、MERS-CoV 和甲型流感病毒的比较综述。
Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020.
8
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.
9
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.用恢复期血浆治疗 COVID-19:从过去的冠状病毒爆发中吸取的教训。
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
10
Overview of lethal human coronaviruses.致死性人类冠状病毒概述。
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. doi: 10.1038/s41392-020-0190-2.

引用本文的文献

1
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells.高度保守的β冠状病毒序列被人类T细胞广泛识别。
Cell. 2025 Jul 30. doi: 10.1016/j.cell.2025.07.015.
2
SARS-CoV-2 ORF7 subgenomic RNA and Host IFN-β Expression in COVID-19 Hospitalized Patients with Different Prognosis.新冠病毒住院患者中不同预后的严重急性呼吸综合征冠状病毒2开放阅读框7亚基因组RNA与宿主干扰素-β表达
Int J Mol Cell Med. 2025 Jul 1;14(2):726-735. doi: 10.22088/IJMCM.BUMS.14.2.726. eCollection 2025.
3
Discovery of influenza-like virus clades in invertebrates and the evolutionary history and host-shifting events of Orthomyxoviridae in metazoans.

本文引用的文献

1
SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)受体和进入基因在人嗅神经上皮和大脑中表达。
iScience. 2020 Dec 18;23(12):101839. doi: 10.1016/j.isci.2020.101839. Epub 2020 Nov 25.
2
Association between cytokine profiles and lung injury in COVID-19 pneumonia.新型冠状病毒肺炎肺炎中细胞因子谱与肺损伤的关系。
Respir Res. 2020 Jul 29;21(1):201. doi: 10.1186/s12931-020-01465-2.
3
Use of Lung Ultrasound to Differentiate Coronavirus Disease 2019 (COVID-19) Pneumonia From Community-Acquired Pneumonia.
在无脊椎动物中发现类流感病毒进化枝以及后生动物中正粘病毒科的进化历史和宿主转移事件。
Virus Evol. 2025 May 27;11(1):veaf039. doi: 10.1093/ve/veaf039. eCollection 2025.
4
Sex bias determines MERS-CoV infection outcomes in a mouse model of differential pathogenicity.性别偏倚决定了不同致病性小鼠模型中中东呼吸综合征冠状病毒(MERS-CoV)的感染结果。
bioRxiv. 2025 Jun 19:2025.06.19.660369. doi: 10.1101/2025.06.19.660369.
5
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.全基因组siRNA筛选鉴定出对SARS-CoV-2复制及感染后期至关重要的人类宿主因子。
PLoS Biol. 2025 Jun 12;23(6):e3002738. doi: 10.1371/journal.pbio.3002738. eCollection 2025 Jun.
6
5,6-dihydroxyflavone exerts anti-betacoronavirus activity by blocking viral entry to host cells.5,6-二羟基黄酮通过阻断病毒进入宿主细胞发挥抗β冠状病毒活性。
Virus Res. 2025 Jun;356:199578. doi: 10.1016/j.virusres.2025.199578. Epub 2025 Apr 23.
7
Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?Toll样受体在新冠后相关神经退行性疾病中的作用?
Front Med (Lausanne). 2025 Mar 26;12:1458281. doi: 10.3389/fmed.2025.1458281. eCollection 2025.
8
Viral inactivation of murine coronavirus via multiple gas plasma-derived reactive species.通过多种气体等离子体衍生的活性物质对鼠冠状病毒进行病毒灭活
Redox Biol. 2025 May;82:103591. doi: 10.1016/j.redox.2025.103591. Epub 2025 Mar 10.
9
An Active-Learning Framework for Educating Medical Students on SARS-CoV-2 Variants and COVID-19 Epidemiology.一个用于教育医学生关于SARS-CoV-2变体和COVID-19流行病学的主动学习框架。
MedEdPublish (2016). 2024 Nov 15;14:279. doi: 10.12688/mep.20540.1. eCollection 2024.
10
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma.用于测定新冠病毒治疗药物法匹拉韦和硝唑尼特的生态可持续色谱法:应用于人体血浆
BMC Chem. 2025 Jan 9;19(1):11. doi: 10.1186/s13065-024-01364-3.
应用肺部超声鉴别 2019 年冠状病毒病(COVID-19)肺炎与社区获得性肺炎。
Ultrasound Med Biol. 2020 Oct;46(10):2651-2658. doi: 10.1016/j.ultrasmedbio.2020.05.006. Epub 2020 Jun 5.
4
The COVID-19 Cytokine Storm; What We Know So Far.《COVID-19 细胞因子风暴:目前我们所了解的》。
Front Immunol. 2020 Jun 16;11:1446. doi: 10.3389/fimmu.2020.01446. eCollection 2020.
5
Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.基因组:基因组信息如何用于应对过去的疫情爆发和 COVID-19 大流行。
Int J Mol Sci. 2020 Jun 26;21(12):4546. doi: 10.3390/ijms21124546.
6
Emerging Prevention and Treatment Strategies to Control COVID-19.控制新冠病毒病的新兴预防和治疗策略
Pathogens. 2020 Jun 23;9(6):501. doi: 10.3390/pathogens9060501.
7
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.肺泡巨噬细胞功能障碍和细胞因子风暴在两例严重 COVID-19 患者发病机制中的作用。
EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20.
8
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.对 COVID-19 病理学发现的系统回顾:疾病进展的病理生理学时间轴和可能机制。
Mod Pathol. 2020 Nov;33(11):2128-2138. doi: 10.1038/s41379-020-0603-3. Epub 2020 Jun 22.
9
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.
10
Identifying airborne transmission as the dominant route for the spread of COVID-19.确定空气传播是 COVID-19 传播的主要途径。
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857-14863. doi: 10.1073/pnas.2009637117. Epub 2020 Jun 11.